drugset / Trial / NCT00009061

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

NCT00009061

Phase 3 Unknown 624 enrolled Glaxo Wellcome
Treatment

Summary

The purpose of this study is to compare virus response to GW433908/ritonavir (RTV) to viral response to nelfinavir (NFV) when used with abacavir (ABC)/lamivudine (3TC) in patients that have not taken antiretroviral (ART) drugs.

Timeline

Start
2000-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fosamprenavir Small molecule
Subject Nelfinavir Other / unclassified
Subject Ritonavir Other / unclassified
Background Abacavir Other / unclassified
Background Lamivudine Other / unclassified